STOCK PURCHASE AGREEMENT By and Between ZAI LAB LIMITED AND MACROGENICS, INC. Dated as of June 14, 2021Stock Purchase Agreement • July 29th, 2021 • Macrogenics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of June 14, 2021, by and between Zai Lab Limited (the “Investor”), an exempted company with limited liabilities incorporated under the Laws of Cayman Islands with its principal place of business at Fourth Floor, Building 1,4560 Jinke Road, Pudong District, Shanghai 201210, China, and MacroGenics, Inc. (the “Company”), a Delaware corporation, with its principal place of business at 9704 Medical Center Drive, Rockville, MD 20850.
COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • July 29th, 2021 • Macrogenics Inc • Pharmaceutical preparations • New York
Contract Type FiledJuly 29th, 2021 Company Industry JurisdictionThis Collaboration and License Agreement (“Agreement”), effective as of June 15, 2021 (the “Effective Date”), is entered into by and between MacroGenics, Inc., a Delaware corporation with a place of business at 9704 Medical Center Drive, Rockville, MD 20850 (“MacroGenics”), and Zai Lab US LLC, a limited liability company organized under the laws of the State of Delaware, the United States, with a place of business at 1440 O’Brien Drive, Suite C, Menlo Park, CA 94025 (“Zai”). MacroGenics and Zai may be referred to herein individually as a “Party” or collectively as the “Parties”.